Information Provided By: 
Fly News Breaks for January 23, 2020
SYK, NVRO, MDT, ITGR, BSX, AVNS
Jan 23, 2020 | 08:23 EDT
NANS 2020 Conference will b e held in Las Vegas on January 23-26.
News For AVNS;BSX;ITGR;MDT;NVRO;SYK From the Last 2 Days
BSX
Apr 25, 2024 | 08:51 EDT
BSX
Apr 25, 2024 | 08:26 EDT
BSX
Apr 25, 2024 | 08:24 EDT
Evercore ISI analyst Vijay Kumar raised the firm's price target on Boston Scientific to $78 from $72 and keeps an Outperform rating on the shares as the firm said the company reported "solid results and there wasn't much to pick on." While EP franchise acceleration driven by Farapulse PFA launch "is generally well known" by the Street, the firm says it doesn't think "anyone expected ~86% US growth and ~72% International growth."
ITGR
Apr 25, 2024 | 08:05 EDT
ITGR
Apr 25, 2024 | 08:03 EDT
Reports Q1 revenue $414.8M, consensus $412.82M. "Integer started the year strong with first quarter 2024 sales growing 10% versus a year ago and adjusted operating income growing 26%, more than two and a half times the rate of sales growth." said Joseph Dziedzic, Integer's president and CEO. "We continue to expect 2024 sales growth of 9% to 11% and adjusted operating income growth of 13% to 20% in 2024, as we execute our strategy and expand margins throughout the year."
BSX
Apr 25, 2024 | 06:59 EDT
BSX
Apr 25, 2024 | 06:47 EDT
BSX
Apr 25, 2024 | 06:37 EDT
BSX
Apr 25, 2024 | 06:29 EDT
Baird analyst David Rescott raised the firm's price target on Boston Scientific to $84 from $79 and keeps an Outperform rating on the shares. The firm noted its 1Q24 revenue/adjusted EPS beat was the biggest over the past several years and one of the most compelling in diversified LGCP MedTech.
BSX
Apr 25, 2024 | 06:22 EDT
BSX
Apr 24, 2024 | 16:20 EDT
BSX
Apr 24, 2024 | 13:53 EDT
Stifel raised the firm's price target on Boston Scientific to $83 from $70 and keeps a Buy rating on the shares. The firm said the company delivered "solid" Q1 outperformance, underpinned by "important" new product launches. Looking ahead to 2024 and beyond, Stifel believes Boston Scientific could continue outperforming their Loan Repayment Program and the firm's projections.
BSX
Apr 24, 2024 | 08:50 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
BSX
Apr 24, 2024 | 07:03 EDT
BSX
Apr 24, 2024 | 07:01 EDT
BSX
Apr 24, 2024 | 07:00 EDT
